A new study reveals that generic drugs manufactured in India have a higher association with severe adverse events such as ...

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than ...

Arrowhead Pharmaceuticals stock could remain under pressure in the near-term, but improved financial outlook and pipeline progress put it in a strong position to deliver long-term gains.

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds.